MedPath

Ampicillin and Sulbactam

AMPICILLIN AND SULBACTAM FOR INJECTION, USP

Approved
Approval ID

9a722de6-9dc0-4fb9-b63a-225385aa3314

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 23, 2023

Manufacturers
FDA

WG Critical Care, LLC

DUNS: 829274633

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ampicillin and Sulbactam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code44567-211
Application NumberANDA065176
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ampicillin and Sulbactam
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 23, 2023
FDA Product Classification

INGREDIENTS (3)

SULBACTAM SODIUMActive
Quantity: 1 g in 20 mL
Code: DKQ4T82YE6
Classification: ACTIM
AMPICILLIN SODIUMActive
Quantity: 2 g in 20 mL
Code: JFN36L5S8K
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 20 mL
Code: 2LQ0UUW8IN
Classification: CNTM

Ampicillin and Sulbactam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code44567-210
Application NumberANDA065176
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ampicillin and Sulbactam
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 23, 2023
FDA Product Classification

INGREDIENTS (3)

AMPICILLIN SODIUMActive
Quantity: 1 g in 10 mL
Code: JFN36L5S8K
Classification: ACTIM
SULBACTAM SODIUMActive
Quantity: 0.5 g in 10 mL
Code: DKQ4T82YE6
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 10 mL
Code: 2LQ0UUW8IN
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ampicillin and Sulbactam - FDA Drug Approval Details